Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. VERA
VERA logo

VERA

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

VERA News

TRUTAKNA Receives FDA Accelerated Approval for IgAN Treatment

1d agoNewsfilter

Vera Therapeutics Receives FDA Accelerated Approval for TRUTAKNA

12h agoNASDAQ.COM

Freedom Holding Corp Sees Surge in Options Trading Volume

22h agoNASDAQ.COM

Vera Therapeutics' Trutakna Receives FDA Approval for IgAN

23h agostocktwits

Vera Therapeutics' Kidney Therapy Receives FDA Approval

1d agoseekingalpha

Vera Therapeutics' Atacicept FDA Decision Approaches, Stock Rises

2d agostocktwits

FDA to Announce Multiple Therapy Decisions in July

Jul 01 2026NASDAQ.COM

Vera Therapeutics Advances Atacicept for IgA Nephropathy with FDA Agreement

Jun 02 2026stocktwits

Vera Therapeutics Accelerates Atacicept Approval Process

Jun 02 2026Newsfilter

Rhenman Exits Entire Stake in Vera Therapeutics

May 26 2026Fool

Rhenman & Partners Exits Entire Stake in Vera Therapeutics

May 26 2026NASDAQ.COM

Vera Therapeutics Reports Q1 Financial Results

May 07 2026seekingalpha

Vera Therapeutics to Present at Bank of America Health Care Conference

May 04 2026Newsfilter

Vera Therapeutics Grants Stock Awards to New Employees

Apr 10 2026Newsfilter

Vera Therapeutics Grants Stock Awards to New Chief Legal Officer

Mar 27 2026Newsfilter

Vera Therapeutics Appoints New Chief Legal Officer

Mar 25 2026Newsfilter